テストステロン補充療法の世界市場2020-2026:ゲル、注射剤、パッチ、その他

QYResearchが発行した調査報告書(QYR20AP02429)
◆英語タイトル:Global Testosterone Replacement Therapy Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02429
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、テストステロン補充療法の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、テストステロン補充療法のグローバル市場動向、メーカー別競争状況、種類別市場規模(ゲル、注射剤、パッチ、その他)、用途別市場規模(病院、診療所、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・テストステロン補充療法の種類別市場2015-2026:ゲル、注射剤、パッチ、その他
・テストステロン補充療法の用途別市場2015-2026:病院、診療所、その他
・テストステロン補充療法の北米市場分析
・テストステロン補充療法のアジア市場分析
・テストステロン補充療法の中南米市場分析
・テストステロン補充療法の中東・アフリカ市場分析
・関連企業情報:AbbVie、Endo International、Eli lilly、Pfizer、Actavis (Allergan)、Bayer、Novartis、Teva、Mylan、Upsher-Smith、Ferring Pharmaceuticals、Kyowa Kirin、Acerus Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.

Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.

North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.

Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)
Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2019, the global Testosterone Replacement Therapy market size was US$ 1665.5 million and is forecast to US$ 1238.2 million in 2026, growing at a CAGR of -4.1% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Testosterone Replacement Therapy.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Testosterone Replacement Therapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Testosterone Replacement Therapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Testosterone Replacement Therapy market. Readers of the report can become informed about current and future trends of the global Testosterone Replacement Therapy market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Testosterone Replacement Therapy markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Testosterone Replacement Therapy market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Testosterone Replacement Therapy market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Testosterone Replacement Therapy market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Testosterone Replacement Therapy market is segmented into
Gels
Injections
Patches
Other

Market Segment by Application, the Testosterone Replacement Therapy market is segmented into
Hospitals
Clinics
Others

This report includes the following manufacturers; we can also add the other companies as you want.
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals

The study objectives are:
To analyze and research the global Testosterone Replacement Therapy status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Testosterone Replacement Therapy manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Testosterone Replacement Therapy are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Testosterone Replacement Therapy Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Testosterone Replacement Therapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Gels
1.3.3 Injections
1.3.4 Patches
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Testosterone Replacement Therapy Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Testosterone Replacement Therapy Revenue (2015-2026)
2.1.1 Global Testosterone Replacement Therapy Revenue (2015-2026)
2.1.2 Global Testosterone Replacement Therapy Sales (2015-2026)
2.2 Testosterone Replacement Therapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Testosterone Replacement Therapy Sales by Regions (2015-2020)
2.2.2 Global Testosterone Replacement Therapy Revenue by Regions (2015-2020)
2.3 Global Top Testosterone Replacement Therapy Regions (Countries) Ranking by Market Size
2.4 Testosterone Replacement Therapy Industry Trends
2.4.1 Testosterone Replacement Therapy Market Top Trends
2.4.2 Market Drivers
2.4.3 Testosterone Replacement Therapy Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Testosterone Replacement Therapy Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Testosterone Replacement Therapy Manufacturers by Sales (2015-2020)
3.1.1 Global Testosterone Replacement Therapy Sales by Manufacturers (2015-2020)
3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Testosterone Replacement Therapy Sales in 2019
3.2 Global Top Manufacturers Testosterone Replacement Therapy by Revenue
3.2.1 Global Testosterone Replacement Therapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Testosterone Replacement Therapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Testosterone Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testosterone Replacement Therapy as of 2019)
3.4 Global Testosterone Replacement Therapy Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Testosterone Replacement Therapy Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Testosterone Replacement Therapy Market
3.7 Key Manufacturers Testosterone Replacement Therapy Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Testosterone Replacement Therapy Historic Market Review by Type (2015-2020)
4.1.2 Global Testosterone Replacement Therapy Sales Market Share by Type (2015-2020)
4.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Type (2015-2020)
4.1.4 Testosterone Replacement Therapy Price by Type (2015-2020)
4.1 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Testosterone Replacement Therapy Sales Forecast by Type (2021-2026)
4.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Type (2021-2026)
4.2.4 Testosterone Replacement Therapy Price Forecast by Type (2021-2026)

5 Global Testosterone Replacement Therapy Market Size by Application
5.1 Global Testosterone Replacement Therapy Historic Market Review by Application (2015-2020)
5.1.2 Global Testosterone Replacement Therapy Sales Market Share by Application (2015-2020)
5.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Application (2015-2020)
5.1.4 Testosterone Replacement Therapy Price by Application (2015-2020)
5.2 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Testosterone Replacement Therapy Sales Forecast by Application (2021-2026)
5.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Application (2021-2026)
5.2.4 Testosterone Replacement Therapy Price Forecast by Application (2021-2026)

6 North America
6.1 North America Testosterone Replacement Therapy Breakdown Data by Company
6.2 North America Testosterone Replacement Therapy Breakdown Data by Type
6.3 North America Testosterone Replacement Therapy Breakdown Data by Application
6.4 North America Testosterone Replacement Therapy Breakdown Data by Countries
6.4.1 North America Testosterone Replacement Therapy Sales by Countries
6.4.2 North America Testosterone Replacement Therapy Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Testosterone Replacement Therapy Breakdown Data by Company
7.2 Europe Testosterone Replacement Therapy Breakdown Data by Type
7.3 Europe Testosterone Replacement Therapy Breakdown Data by Application
7.4 Europe Testosterone Replacement Therapy Breakdown Data by Countries
7.4.1 Europe Testosterone Replacement Therapy Sales by Countries
7.4.2 Europe Testosterone Replacement Therapy Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Company
8.2 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Type
8.3 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Application
8.4 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Regions
8.4.1 Asia Pacific Testosterone Replacement Therapy Sales by Regions
8.4.2 Asia Pacific Testosterone Replacement Therapy Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Testosterone Replacement Therapy Breakdown Data by Company
9.2 Latin America Testosterone Replacement Therapy Breakdown Data by Type
9.3 Latin America Testosterone Replacement Therapy Breakdown Data by Application
9.4 Latin America Testosterone Replacement Therapy Breakdown Data by Countries
9.4.1 Latin America Testosterone Replacement Therapy Sales by Countries
9.4.2 Latin America Testosterone Replacement Therapy Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Type
10.2 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Application
10.3 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Countries
10.3.1 Middle East and Africa Testosterone Replacement Therapy Sales by Countries
10.3.2 Middle East and Africa Testosterone Replacement Therapy Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AbbVie Testosterone Replacement Therapy Products and Services
11.1.5 AbbVie SWOT Analysis
11.1.6 AbbVie Recent Developments
11.2 Endo International
11.2.1 Endo International Corporation Information
11.2.2 Endo International Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Endo International Testosterone Replacement Therapy Products and Services
11.2.5 Endo International SWOT Analysis
11.2.6 Endo International Recent Developments
11.3 Eli lilly
11.3.1 Eli lilly Corporation Information
11.3.2 Eli lilly Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Eli lilly Testosterone Replacement Therapy Products and Services
11.3.5 Eli lilly SWOT Analysis
11.3.6 Eli lilly Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Testosterone Replacement Therapy Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Actavis (Allergan)
11.5.1 Actavis (Allergan) Corporation Information
11.5.2 Actavis (Allergan) Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Actavis (Allergan) Testosterone Replacement Therapy Products and Services
11.5.5 Actavis (Allergan) SWOT Analysis
11.5.6 Actavis (Allergan) Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Bayer Testosterone Replacement Therapy Products and Services
11.6.5 Bayer SWOT Analysis
11.6.6 Bayer Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Novartis Testosterone Replacement Therapy Products and Services
11.7.5 Novartis SWOT Analysis
11.7.6 Novartis Recent Developments
11.8 Teva
11.8.1 Teva Corporation Information
11.8.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Teva Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Teva Testosterone Replacement Therapy Products and Services
11.8.5 Teva SWOT Analysis
11.8.6 Teva Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Mylan Testosterone Replacement Therapy Products and Services
11.9.5 Mylan SWOT Analysis
11.9.6 Mylan Recent Developments
11.10 Upsher-Smith
11.10.1 Upsher-Smith Corporation Information
11.10.2 Upsher-Smith Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Upsher-Smith Testosterone Replacement Therapy Products and Services
11.10.5 Upsher-Smith SWOT Analysis
11.10.6 Upsher-Smith Recent Developments
11.11 Ferring Pharmaceuticals
11.11.1 Ferring Pharmaceuticals Corporation Information
11.11.2 Ferring Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Products and Services
11.11.5 Ferring Pharmaceuticals SWOT Analysis
11.11.6 Ferring Pharmaceuticals Recent Developments
11.12 Kyowa Kirin
11.12.1 Kyowa Kirin Corporation Information
11.12.2 Kyowa Kirin Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Kyowa Kirin Testosterone Replacement Therapy Products and Services
11.12.5 Kyowa Kirin SWOT Analysis
11.12.6 Kyowa Kirin Recent Developments
11.13 Acerus Pharmaceuticals
11.13.1 Acerus Pharmaceuticals Corporation Information
11.13.2 Acerus Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Products and Services
11.13.5 Acerus Pharmaceuticals SWOT Analysis
11.13.6 Acerus Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Testosterone Replacement Therapy Sales Channels
12.2.2 Testosterone Replacement Therapy Distributors
12.3 Testosterone Replacement Therapy Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.1.1 Global Testosterone Replacement Therapy Sales Forecast by Regions (2021-2026)
13.1.2 Global Testosterone Replacement Therapy Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.2.2 North America Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.2.3 North America Testosterone Replacement Therapy Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.3.2 Europe Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.3.3 Europe Testosterone Replacement Therapy Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.4.2 Asia Pacific Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Testosterone Replacement Therapy Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.5.2 Latin America Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.5.3 Latin America Testosterone Replacement Therapy Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Testosterone Replacement Therapy Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

AbbVie、Endo International、Eli lilly、Pfizer、Actavis (Allergan)、Bayer、Novartis、Teva、Mylan、Upsher-Smith、Ferring Pharmaceuticals、Kyowa Kirin、Acerus Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ テストステロン補充療法の世界市場2020-2026:ゲル、注射剤、パッチ、その他(Global Testosterone Replacement Therapy Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。